PubMed HealthSearch

PubMed · 9830223

[Multi-dimensional analysis of vocal function. A case-control study].

Abstract

The aim of this study was to select the most appropriate methods for analyzing vocal function from an array of existing tests. A case-control study (64 patients and 64 controls) was made of teaching staff in Logroño, Spain. The 64 patients had 25 nodules, 7 polyps, 15 hyperfunctional dysphonia, 6 hypofunctional dysphonia, 6 submucosal suffusion and 5 chronic laryngitis. The study methods included anamnesis, ENT examination, videostrobolaryngoscopy, perceptual evaluation of hoarse voices, basic aerodynamic tests, the frequency range of phonation, physical analysis of the voice signal of the vowel /a/ and the sentence ìmi padre era castellanoî, and spectrographic analysis of Spanish vowels according to Yanagiharaís classification using Sound Scope 1.0 software. We found no single test that consistently differentiated between hoarse and normal voices; values always overlapped. In contrast the phonation quotient (PQ), maximum phonation time (MPT) of the vowel /a/, S/Z quotient (Eckel and Boone), frequency range of phonation, APQ (average perturbation quotient), HNR (harmonic-to-noise ratio), BR (breathiness, or the high-frequency content of the source wave), RAP (relative average perturbation), standard deviation (SD) of the fundamental frequency (F0) of the vowel /a/, intensity and SD of the sentence ìmi padre era castellanoî, and the sound spectrographic analysis of Spanish vowels disclosed statistically significant differences between hoarse and normal voices.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J A Preciado, R García Tapia, J C Infante. [Multi-dimensional analysis of vocal function. A case-control study].. https://pubmed.ncbi.nlm.nih.gov/9830223/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Relation between systemic hypertension and blood lipids on the risk of myocardial infarction.

We sought to evaluate the potential interactions between systemic hypertension and blood lipids on the risk of myocardial infarction (MI). Recent evidence suggests that hypertension may interact with other risk factors such as dyslipidemia in the development of coronary heart disease. However, the precise nature of that interrelation remains unclear. We selected 340 cases of first MI and an equal number of age-, sex-, and community-matched controls. Data were collected on a large number of coronary risk factors, and fasting blood samples were obtained. Logistic regression was used to calculate the odds ratio (OR) of nonfatal MI. The age- and sex-adjusted OR of MI was 1.61 (95% confidence interval [CI] 1.15 to 2.25) among treated hypertensives compared with nonhypertensives. Further adjustment for coronary risk factors did not materially alter the results (OR 1.67, 95% CI 1.16 to 2.41). To explore the interrelations among hypertension, lipids, and risk of MI, each lipoprotein parameter was individually added to the risk factor-adjusted multivariate model. The apparent risk associated with hypertension was substantially attenuated by the addition of either high-density lipoprotein cholesterol (OR 1.25, 95% CI 0.82 to 1.90) or triglycerides (OR 1.37, 95% CI 0.91 to 2.05). No significant interactions were found between hypertension and any lipoprotein parameter. These data indicate that the risk of MI associated with treated hypertension may have a lipid mechanism involving high-density lipoprotein cholesterol and/or triglycerides.

Case-Control Studies

Association of maternal IgM concentrations above the median at 15-19 weeks of gestation and early preterm delivery.

IgM concentrations greater than the median in maternal serum collected at 15-19 weeks of pregnancy were strongly associated (odds ratio 15.6) with delivery before 29 weeks. Our results suggest that the postulated inflammatory component in the aetiology of very preterm delivery may elicit a measurable maternal humoral response as early as mid-trimester.

Case-Control Studies